ArticleBMC psychiatry2019
Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial.
Sanne Y Smith-Apeldoorn et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this paperpooled ittrialcites it